Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic trials with tobramycin.

× No keyword cloud information.

11 in total

1. Piperacillin: in vitro evaluation.

Authors: G P Bodey; B Le Blanc
Journal: Antimicrob Agents Chemother Date: 1978-07 Impact factor: 5.191

2. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.

Authors: B de Pauw; K Williams; J de Neeff; T Bothof; T de Witte; R Holdrinet; C Haanen
Journal: Antimicrob Agents Chemother Date: 1985-12 Impact factor: 5.191

Review 3. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.

Authors: J W Hathorn; M Rubin; P A Pizzo
Journal: Antimicrob Agents Chemother Date: 1987-07 Impact factor: 5.191

4. The use of tombramycin in the management of severe infections. Clinical and pharmacological data.

Authors: D Baron; H Drugeon; F Nicolas; A Courtieu
Journal: Eur J Intensive Care Med Date: 1976-09

Review 5. Why monitor serum levels of gentamicin?

Authors: M Barza; M Lauermann
Journal: Clin Pharmacokinet Date: 1978 May-Jun Impact factor: 6.447

Review 6. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors: R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal: Drugs Date: 1976 Impact factor: 9.546

7. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.

Authors: T J Marrie; M J Gurwith; A R Ronald; H G Stiver; B Lank; L Fox
Journal: Can Med Assoc J Date: 1977-07-23 Impact factor: 8.262

8. Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.

Authors: L Jadeja; R Bolivar; V Fainstein; M Keating; K McCredie; M Hay; G P Bodey
Journal: Antimicrob Agents Chemother Date: 1984-09 Impact factor: 5.191

9. Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Authors: J C Wade; S C Schimpff; K A Newman; C L Fortner; M R Moody; V M Young; P H Wiernik
Journal: Antimicrob Agents Chemother Date: 1980-08 Impact factor: 5.191

10. Mezlocillin for treatment of infections in cancer patients.

Authors: B F Issell; G P Bodey
Journal: Antimicrob Agents Chemother Date: 1980-06 Impact factor: 5.191